Terms: = Colorectal cancer AND BCL10, CIPER, 8915, ENSG00000142867, c-E10, CARMEN, mE10, CLAP
12 results:
1. Identification of gut microbes-related molecular subtypes and their biomarkers in colorectal cancer.
Liu X; Zhang G; Li S; Liu Y; Ma K; Wang L
Aging (Albany NY); 2024 Jan; 16(3):2249-2272. PubMed ID: 38289597
[TBL] [Abstract] [Full Text] [Related]
2. Identification and validation of a seven-gene prognostic marker in colon cancer based on single-cell transcriptome analysis.
Zhou Y; Guo Y; Wang Y
IET Syst Biol; 2022 Apr; 16(2):72-83. PubMed ID: 35352485
[TBL] [Abstract] [Full Text] [Related]
3. A novel hand-assisted laparoscopic versus conventional laparoscopic right hemicolectomy for right colon cancer: study protocol for a randomized controlled trial.
Yang X; Wu Q; Jin C; He W; Wang M; Yang T; Wei M; Deng X; Meng W; Wang Z
Trials; 2017 Jul; 18(1):355. PubMed ID: 28747220
[TBL] [Abstract] [Full Text] [Related]
4. PHLPP2 suppresses the NF-κB pathway by inactivating IKKβ kinase.
Agarwal NK; Zhu X; Gagea M; White CL; Cote G; Georgescu MM
Oncotarget; 2014 Feb; 5(3):815-23. PubMed ID: 24553260
[TBL] [Abstract] [Full Text] [Related]
5. Expression of CARD6, an NF-kappaB activator, in gastric, colorectal and oesophageal cancers.
Kim SS; Ahn CH; Kang MR; Kim YR; Kim HS; Yoo NJ; Lee SH
Pathology; 2010 Jan; 42(1):50-3. PubMed ID: 20025480
[TBL] [Abstract] [Full Text] [Related]
6. Colonic carcinoma with a pancreatic acinar cell differentiation. A case report.
Chiaravalli AM; Finzi G; Bertolini V; La Rosa S; Capella C
Virchows Arch; 2009 Dec; 455(6):527-31. PubMed ID: 19908063
[TBL] [Abstract] [Full Text] [Related]
7. Associations between ERalpha, ERbeta, and AR genotypes and colon and rectal cancer.
Slattery ML; Sweeney C; Murtaugh M; Ma KN; Wolff RK; Potter JD; Caan BJ; Samowitz W
Cancer Epidemiol Biomarkers Prev; 2005 Dec; 14(12):2936-42. PubMed ID: 16365013
[TBL] [Abstract] [Full Text] [Related]
8. Role of the hMLH1 DNA mismatch repair protein in fluoropyrimidine-mediated cell death and cell cycle responses.
Meyers M; Wagner MW; Hwang HS; Kinsella TJ; Boothman DA
Cancer Res; 2001 Jul; 61(13):5193-201. PubMed ID: 11431359
[TBL] [Abstract] [Full Text] [Related]
9. Absence of post-transcriptional RNA modifications of bcl10 in human malignant mesothelioma and colorectal cancer.
Apostolou S; Murthy SS; Kolachana P; Jhanwar SC; Testa JR
Genes Chromosomes Cancer; 2001 Jan; 30(1):96-8. PubMed ID: 11107182
[TBL] [Abstract] [Full Text] [Related]
10. Point mutations and deletions of the bcl10 gene in solid tumors and malignant lymphomas.
Lee SH; Shin MS; Kim HS; Park WS; Kim SY; Lee HK; Park JY; Oh RR; Jang JJ; Park KM; Han JY; Kang CS; Lee JY; Yoo NJ
Cancer Res; 1999 Nov; 59(22):5674-7. PubMed ID: 10582682
[TBL] [Abstract] [Full Text] [Related]
11. bcl10 is not a target for frequent mutation in human carcinomas.
Lambers AR; Gumbs C; Ali S; Marks JR; Iglehart JD; Berchuck A; Futreal PA
Br J Cancer; 1999 Jul; 80(10):1575-6. PubMed ID: 10408401
[TBL] [Abstract] [Full Text] [Related]
12. Mutations in bcl10 are very rare in colorectal cancer.
Stone JG; Rowan AJ; Tomlinson IP; Houlston RS
Br J Cancer; 1999 Jul; 80(10):1569-70. PubMed ID: 10408399
[TBL] [Abstract] [Full Text] [Related]